Cochrane Abstracts
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angiotensin‐converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Preserving Residual Kidney Function in Peritoneal Dialysis Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433807/all/Angiotensin‐converting_enzyme_inhibitors_and_angiotensin_receptor_blockers_for_preserving_residual_kidney_function_in_peritoneal_dialysis_patients.
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433807/all/Angiotensin‐converting_enzyme_inhibitors_and_angiotensin_receptor_blockers_for_preserving_residual_kidney_function_in_peritoneal_dialysis_patients. Accessed January 21, 2025.
Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433807/all/Angiotensin‐converting_enzyme_inhibitors_and_angiotensin_receptor_blockers_for_preserving_residual_kidney_function_in_peritoneal_dialysis_patients
Angiotensin‐converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Preserving Residual Kidney Function in Peritoneal Dialysis Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433807/all/Angiotensin‐converting_enzyme_inhibitors_and_angiotensin_receptor_blockers_for_preserving_residual_kidney_function_in_peritoneal_dialysis_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
ID - 433807
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433807/all/Angiotensin‐converting_enzyme_inhibitors_and_angiotensin_receptor_blockers_for_preserving_residual_kidney_function_in_peritoneal_dialysis_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
